From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

relatlimab   Click here for help

GtoPdb Ligand ID: 9536

Synonyms: BMS-986016 | BMS986016 | ONO-4482 | Opdualag® (nivolumab + relatlimab-rmbw) | relatlimab-rmbw
Approved drug Immunopharmacology Ligand
relatlimab is an approved drug (EMA & FDA (2022))
Compound class: Antibody
Comment: Relatlimab (BMS-986016) is an anti-LAG3 monoclonal antibody that was developed for utility in cancer immunotherapy.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
LAG3 (CD223) Primary target of this compound Hs Antibody Antagonist - - - 2
⤷ [2]